Zentek Ltd. (ZTEK)

USD 0.98

(-4.85%)

Market Cap (In USD)

101.98 Million

Revenue (In USD)

29.81 Thousand

Net Income (In USD)

-11.7 Million

Avg. Volume

26.46 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.5-1.59
PE
-
EPS
-
Beta Value
0.763
ISIN
CA98942X1024
CUSIP
98942X102
CIK
1904501
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Gregory Fenton C.F.A.
Employee Count
-
Website
https://www.zentek.com
Ipo Date
2012-04-02
Details
Zentek Ltd. engages in the research and development of graphene and related nanomaterials in Canada. It owns 100% interest in the Albany Graphite project located in Northern Ontario, Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compound. In addition, it develops synthesize graphene, graphene oxide, and graphene quantum dots for applications of graphene. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Thunder Bay, Canada.